Risk of osteoporotic fractures in new users of denosumab compared with new users of alendronate: A Danish populationbased cohort study

Registros relacionados

• Comparison of risk of osteoporotic fracture in Denosumab vs Alendronate treatment within 3 years of initiation
  por: Pedersen, AB, et al.
  Publicado em: (2019)
• The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus: A Danish Retrospective Cohort Study
  por: Rikke Viggers, et al.
  Publicado em: (2022-01-01)
• Danish clinical quality databases – an important and untapped resource for clinical research
  por: Sørensen HT, et al.
  Publicado em: (2016-10-01)
• Denosumab for the prevention of osteoporotic fractures in postmenopausal women
  por: N Waugh, et al.
  Publicado em: (2011-05-01)
• Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users.
  por: Eiken, P, et al.
  Publicado em: (2017)